Recipients of wild-type T cells succumb to colitis 6–7 weeks after transfer due to the development of IFN-γ+ TH1 cells, but remarkably, when T cells from Bcl3−/− mice were used the recipients remained healthy. Here, BCL3 is linked to colitis.